Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Jan 2025, 18:14.
John E. Kao - 13 Jan 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 13 Jan 2025
- Net transaction value
- -$1,175,494
- SEC form
- 4
- Accepted by SEC
- 13 Jan 2025, 18:14:13 UTC
- Prior SEC filing
- 13 Dec 2024
- Next SEC filing
- 12 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 13 Jan 2025.
Change
- Previous filing in this sequence was filed on 13 Dec 2024.
- Current net transaction value: -$1,175,494.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Sale
- Transaction value
- $671,023
- Shares
- -52,386
- Change %
- -2.2%
- Price
- $12.81
- Shares after
- 2,310,714
- Date
- 13 Jan 2025
- Ownership
- See Footnote
- Footnotes
- F1, F2, F3
ALHC
transaction
Common Stock
Sale
- Transaction value
- $504,471
- Shares
- -37,614
- Change %
- -1.6%
- Price
- $13.41
- Shares after
- 2,273,100
- Date
- 13 Jan 2025
- Ownership
- See Footnote
- Footnotes
- F1, F3, F4
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,745,253
- Date
- 13 Jan 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
Date of Rule 10b5-1 plan adoption: 03/14/2024
Footnote F2
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.23 to $13.22. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Footnote F3
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Footnote F4
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.24 to $13.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.